XiaodongYangMDMS

Cardiothoracic Anesthesiology, Critical Care Medicine

Mount Sinai/ Cedars Sinai

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8700 Beverly Blvd
West Hollywood, CA 90048
Phone+1 310-423-5841

Fax+1 310-423-0387

Icahn School of Medicine at Mount SinaiFellowship, Adult Cardiothoracic Anesthesiology, 2010 - 2011
Icahn School of Medicine at Mount SinaiFellowship, Critical Care Medicine, 2009 - 2010
Johns Hopkins UniversityResidency, Anesthesiology, 2005 - 2009
Flushing Hospital Medical CenterResidency, Internal Medicine, 2002 - 2005
West China University of Medical SciencesClass of 1994

PubMed

3 citations
Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.
Stephen Yang, Brittney Williams, David Kaczorowski, Michael Mazzeffi
The Journal of Extra-Corporeal Technology. 2022-06-01
1 citations
Thrombopoietin, Soluble CD40 Ligand, and Platelet Count During Veno-arterial Extracorporeal Membrane Oxygenation.
Michael A. Mazzeffi, Reney Henderson, Elizabeth K. Powell, Erik Strauss, Brittney Williams
ASAIO Journal. 2021-06-02
1 citations
Utilization of Transverse Abdominis Plexus Block for Treatment of HeartMate II Left Ventricular Assist Device-Associated Pain.
Antonio Hernandez Conte, J. Hajj, Stephen X. Yang, E. Passano, H. Barone
Journal of Cardiothoracic and Vascular Anesthesia. 2017-12-02

Apexigen Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 15th, 2022
Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with ChemotherapyJune 6th, 2022
Apexigen to Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 MelanomaNovember 9th, 2021
Join now to see all